GSK recalls almost 600,000 Ventolin inhalers in US

GSK has voluntarily recalled 593,088 Ventolin inhalers manufactured at its Zebulon, North Carolina facility due to an “Elevated number of units with out of specification results for leak rate.”

The lots involved in the level 2 recall, which was initiated on March 22, 2017, were distributed throughout the United States and Puerto Rico.

In 2015, GSK recalled almost 129,000 Ventolin inhalers manufactured at the same facility due to concerns about insufficient propellant.

Read the FDA enforcement report.